Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex…
Drug Manufacturers - Specialty & Generic
US, Woodcliff Lake [HQ]
Strategy & Leadership
All directors and officers of Eagle Pharmaceuticals, Inc. are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Each datapoint refers the most recent appearance of the corresponding person.
Officers & BofD Beta
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Total Compensation
Shows the total compensation per mentioned executive and board director.Each datapoint refers the most recent appearance of the corresponding person.
- No data, only available if we have DEF 14A compensations in place -
Officers
| Name & Position | Research | Last Appearance | ||
|---|---|---|---|---|
|
Krawtschuk Christopher
Chief Financial Officer
|
11/19/24 [Form 3]
|
|||
|
Cahill Brian Joseph
CHIEF FINANCIAL OFFICER
|
02/29/24 [Form 4]
|
|||
|
Graves Michael
Interim Executive Chair & PEO
Also inside the BofD
|
12/22/23 [Form 4]
|
|||
|
Tarriff Scott
CEO
Also inside the BofD
|
11/03/23 [Form 4]
|
|||
|
Moran Michael Shawn
EVP, Chief Commercial Officer
|
03/02/22 [Form 4]
|
|||
Board of Directors (BofD)
| Name & Position | Research | Last Appearance | ||
|---|---|---|---|---|
|
Ratoff Steven B
Director
|
03/09/23 [Form 4]
|
|||
|
Simpson Jennifer K.
Director
|
03/09/23 [Form 4]
|
|||
|
Glenning Robert
Director
|
03/09/23 [Form 4]
|
|||
|
Edlin Richard A.
Director
|
03/09/23 [Form 4]
|
|||
|
Borio Luciana
Director
|
03/09/23 [Form 4]
|
|||